TG Therapeutics, Inc. (TGTX)

NASDAQ

$53.71

$-0.91

(-1.68%)

Regular Market

TG Therapeutics, Inc. (TGTX) Live Price Chart

Last updated: ⁦2026-10-21 17:00:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

TG Therapeutics, Inc. (TGTX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $53.71, with a market capitalization of $8.16B and a P/E ratio of 18.91. Over the past 52 weeks, its price has ranged from $26.76 to $59.30. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$8.16B
Open	$54.51
Day's High	$59.30
Day's Low	$2.97
Previous Close	$54.53
Volume	408.92K
Average Volume	1.96M
P/E Ratio	18.91
52-Week High	$59.30
52-Week Low	$26.76
Dividend Yield	--
Earnings Date	--

TG Therapeutics, Inc. (TGTX) Stock Price Today

TG Therapeutics, Inc. (TGTX) is currently trading at $53.71 as of 2026-10-21 16:59:00, down 1.51% ($0.82) from the previous close of $54.53

During today's regular trading session, TGTX has traded between $2.97 and $59.30, with a trading volume of 408.92K shares. The current price is near the upper end of today's range.

TG Therapeutics, Inc. (TGTX) 7-Day Stock Price Change

Over the past seven days, TG Therapeutics, Inc. (TGTX) moved from $55.27 to $53.71, representing a decline of 2.83% ($1.56).

The stock traded between $52.90 and $56.83 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 1.32 million shares, down versus the previous seven-day period, indicating lower trading activity.

TGTX 52-Week Price Position

Position in Range: 82.8%

52W Low$26.76

52W High$59.30

TGTX is currently trading at $53.71, placing it 82.8% of the way from its 52-week low of $26.76 to its 52-week high of $59.30. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is TG Therapeutics, Inc. (TGTX)?

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.

TG Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	399
Exchange	NASDAQ
Company Website	https://www.tgtherapeutics.com

How to Buy TG Therapeutics, Inc. (TGTX) Stock on MEXC

Eligible investors can buy real shares of TG Therapeutics, Inc. (TGTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for TGTX and Place Your Order

Open the RealStocks trading page and search for TGTX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is TG Therapeutics, Inc. (TGTX) stock price today?

TG Therapeutics, Inc. (TGTX) is currently trading at $ 53.71, down 1.51% ($0.82) from the previous close of $ 54.53. Intraday prices update in real time during regular trading hours.

2.Is TGTX stock going up or down today?

As of 2026-10-21 16:59:00, TGTX is trading at $ 53.71, down 1.51% ($0.82) from its previous close of $ 54.53. The stock has traded between $ 2.97 and $ 59.30 during today’s regular session. Past price movements do not guarantee future results.

3.What is TGTX pre-market price?

As of 2026-10-21 16:59:00, TGTX is trading at $ 54.75 in pre-market trading, up 0.40% ($0.22) from the previous close of $ 54.53. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is TGTX after-hours price?

As of 2026-10-21 16:59:00, TGTX is trading at $ 54.47 in after-hours trading, down 0.12% ($0.06) from the regular-session close of $ 54.53. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is TGTX stock trading now?

TGTX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does TGTX sit relative to its 52-week high and low?

Over the past 52 weeks, TGTX has traded between a low of $ 26.76 and a high of $ 59.30. At $ 53.71, the stock is positioned 82.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is TG Therapeutics, Inc. in?

TG Therapeutics, Inc. (TGTX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is TG Therapeutics, Inc.'s market capitalization and where is it listed?

TG Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 8.16B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is TGTX valued in terms of P/E ratio and EPS?

TGTX trades at a P/E ratio of 18.91, based on trailing-twelve-month EPS of $ 2.88. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does TG Therapeutics, Inc. pay a dividend?

TG Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.